Sai Life Sciences Limited (NSE: SAILIFE) stock price gains 5% intraday, breaking out above its 6-month resistance trendline at ₹1342.
Sai Life Sciences Limited (SAILIFE) reports Q1 FY27 results with ₹554 crore revenue, up 12% YoY, strong CRO growth and sustained pipeline.
Sai Life Sciences Limited (SAILIFE) reports a 29% revenue increase and a 56% EBITDA rise for FY26, driven by strong execution and strategic investments.
Sai Life Sciences Limited becomes the first Indian CRDMO with a site powered by 100% renewable energy, achieving sustainability milestone.